Prejunctional Control of pH 6‐Induced Bronchoconstriction by NK1, NK2, μ‐Opioid, α2‐Adrenoceptor and Glucocorticoid Receptors in Guinea‐pig Isolated Perfused Lung
暂无分享,去创建一个
[1] P. Barnes. Molecular mechanisms of steroid action in asthma. , 1996, The Journal of allergy and clinical immunology.
[2] J. Brokaw,et al. Effect of dexamethasone treatment on the regional distribution of neutral endopeptidase activity in the rat trachea , 1995, Neuropeptides.
[3] A. Sisto,et al. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea‐pig ileum and proximal colon , 1994, British journal of pharmacology.
[4] E. Wolfgang,et al. Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors. , 1994, European journal of pharmacology.
[5] R. Håkanson,et al. Non‐specific actions of the non‐peptide tachykinin receptor antagonists, CP‐96, 345, RP 67580 and SR 48968, on neurotransmission , 1994, British journal of pharmacology.
[6] P. Soubrié,et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. , 1993, European journal of pharmacology.
[7] J. Lundberg,et al. Lactic acid-induced plasma protein extravasation in rat airways by stimulation of sensory nerves and NK1 receptor activation. , 1993, Pharmacology & toxicology.
[8] H. Inoue,et al. Profile of capsaicin‐induced mouse ear oedema as neurogenic inflammatory model: comparison with arachidonic acid‐induced ear oedema , 1993, British journal of pharmacology.
[9] L. Y. Lee,et al. Postjunctional inhibitory effect of the NK2 receptor antagonist, SR 48968, on sensory NANC bronchoconstriction in the guinea‐pig , 1993, British journal of pharmacology.
[10] J. Hieble,et al. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes. , 1993, Annual review of pharmacology and toxicology.
[11] J. Lundberg,et al. Inhibition of low pH evoked activation of airway sensory nerves by capsazepine, a novel capsaicin-receptor antagonist. , 1992, Biochemical and biophysical research communications.
[12] A. Franco‐Cereceda,et al. Capsazepine inhibits low pH- and lactic acid-evoked release of calcitonin gene-related peptide from sensory nerves in guinea-pig heart. , 1992, European journal of pharmacology.
[13] A. Franco‐Cereceda,et al. Variable alpha 2-adrenoceptor-mediated inhibition of bronchoconstriction and peptide release upon activation of pulmonary afferents. , 1992, European journal of pharmacology.
[14] E. Naline,et al. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. , 1992, Life sciences.
[15] C. Maggi,et al. Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: Mechanism of action and biological response , 1991, Neuroscience.
[16] L. Garraway,et al. Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones. , 1991, Biochemistry.
[17] C. Maggi,et al. Tachykinin receptors in the guinea-pig isolated bronchi. , 1991, European journal of pharmacology.
[18] J. Howbert,et al. Species differences in affinities of non-peptide antagonists for substance P receptors. , 1991, European journal of pharmacology.
[19] S. Bevan,et al. Protons activate a cation conductance in a sub‐population of rat dorsal root ganglion neurones. , 1991, The Journal of physiology.
[20] D. Gruenert,et al. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. , 1991, The American journal of physiology.
[21] J. Lowe,et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.
[22] S. Nakanishi,et al. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. , 1990, The Journal of biological chemistry.
[23] W. Hutchison,et al. Morphine does not reduce the intraspinal release of calcitonin gene-related peptide in the cat , 1990, Neuroscience Letters.
[24] J. Karlsson,et al. Capsaicin-induced bronchoconstriction and neuropeptide release in guinea pig perfused lungs. , 1990, Journal of applied physiology.
[25] A. Carayon,et al. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord , 1989, Neuropeptides.
[26] R. Matran,et al. Inhibition of cholinergic and non-adrenergic, non-cholinergic bronchoconstriction in the guinea pig mediated by neuropeptide Y and alpha 2-adrenoceptors and opiate receptors. , 1989, European journal of pharmacology.
[27] K. Chung,et al. Opioid modulation of non‐cholinergic neural bronchoconstriction in guinea‐pig in vivo , 1988, British journal of pharmacology.
[28] N. Rhaleb,et al. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. , 1987, Life sciences.
[29] P. Portoghese,et al. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice. , 1987, The Journal of pharmacology and experimental therapeutics.
[30] A. Saria,et al. Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. , 1983, Acta physiologica Scandinavica.
[31] E. Brodin,et al. Morphine inhibits substance P release from peripheral sensory nerve endings. , 1983, Acta physiologica Scandinavica.
[32] P. Wood,et al. Multiple opiate receptors: Differential binding of μ, κ and δ agonists , 1981, Neuropharmacology.